SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

BMEA

Biomea Fusion, Inc.
NASDAQHealth Care

Latest close: 0.87 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 14, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 22, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 5, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record27314 flagged findings
Reported transactions (Form 4)72since Dec 28, 2022 · and 12 other holdings
Corporate events (8-K)16since Jun 17, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 273)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 14, 268-K ↗Current report · Communication to the market · Other events new
  • Sep 22, 26424B5 ↗Securities offering
  • Sep 22, 268-K ↗Current report · Other events
  • Aug 5, 2610-Q ↗Quarterly report
  • Aug 5, 268-K ↗Current report · Financial statements and exhibits
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Jun 11, 268-K ↗Current report · Shareholder vote results
  • May 11, 2610-Q ↗Quarterly report
  • May 11, 268-K ↗Current report · Results
  • Apr 28, 268-K ↗Current report · Communication to the market · Other events
  • Apr 27, 26DEF 14A ↗Shareholder meeting and votes
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Mar 24, 2610-K ↗Annual report
  • Mar 24, 268-K ↗Current report · Results
  • Feb 25, 268-K ↗Current report · Communication to the market
  • Feb 17, 26SCHEDULE 13G/A ↗Passive stake · CVI Investments, Inc. · 9.9% · event on Dec 31, 25 · amendment
  • Feb 12, 26SCHEDULE 13G ↗Passive stake · Blue Owl Capital Holdings LP · 5.9% · event on Dec 31, 25
  • Feb 6, 26SCHEDULE 13G/A ↗Passive stake · Rainer M. Erdtmann · 3.9% · event on Dec 31, 25 · amendment
  • Feb 6, 26Form 5 ↗Insider transaction
  • Jan 14, 268-K ↗Current report · Communication to the market · Other events
  • Dec 15, 25Form 4 ↗Insider transaction

273 filings on record, the oldest from Mar 12, 21.

Listing the 25 most recent filings of the 273 on record.

8-Ks, explained

Stress1Structure7Governance8
  • Oct 7, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jul 24, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jun 20, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jun 18, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Mar 27, 25StressListing notice (8-K 3.01)+3 more in the same filing8-K 3.01 ↗
  • Feb 28, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Structure3 material agreements entered2022 – 2023show all 3hide
    • Apr 3, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Nov 25, 22StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
    • Sep 9, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Governance5 senior executive changes2021 – 2022show all 5hide
    • Apr 22, 22GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Jul 12, 21GovernanceA senior executive left or was appointed8-K/A 5.02 ↗
    • Jul 9, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jun 29, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Jun 17, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Chen Bihua1.5%Oct 22, 25SCHEDULE 13D/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • CVI Investments, Inc.9.9%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Blue Owl Capital Holdings LP5.9%Dec 31, 25SCHEDULE 13G ↗2 earlier filings
  • JANUS HENDERSON GROUP PLC5.0%Nov 28, 25SCHEDULE 13G ↗
  • Baker Bros. Advisors LP4.0%Dec 31, 24SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Rainer M. Erdtmann3.9%Dec 31, 25SCHEDULE 13G/A ↗1 earlier filing
show one more holderhide

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Dec 11, 25Buy$43KRainer M ErdtmannSee Remarks↗
  • Dec 2, 25Buy$99KMichael J.M. HitchcockInterim CEO↗
  • Dec 1, 25Buy$11KRainer M ErdtmannSee Remarks↗
  • Nov 28, 25Buy$44KRainer M ErdtmannSee Remarks↗
  • Sep 30, 24Buy$101KMichael J.M. Hitchcock↗
  • Jun 11, 24Buy$55KFranco ValleChief Financial Officer↗
  • Jun 1, 23Sell$1.7MA2A Pharmaceuticals, Inc.↗
  • May 31, 23Sell$2.5MA2A Pharmaceuticals, Inc.↗
  • May 12, 23Sell$846KA2A Pharmaceuticals, Inc.↗
  • May 9, 23Sell$5.2MA2A Pharmaceuticals, Inc.↗
  • May 8, 23Sell$3.4MA2A Pharmaceuticals, Inc.↗
  • Apr 20, 23Sell$5.8MA2A Pharmaceuticals, Inc.↗

There are 2 more transactions in this stretch.

Stock compensation, tax and giftsshow the 26 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Dec 31, 25Giftamount n/aRainer M ErdtmannSee Remarks↗
  • Dec 31, 25Giftamount n/aRainer M ErdtmannSee Remarks↗
  • Dec 31, 25Giftamount n/aRainer M ErdtmannSee Remarks↗
  • Dec 31, 25Giftamount n/aRainer M ErdtmannSee Remarks↗
  • Dec 31, 25Giftamount n/aRainer M ErdtmannSee Remarks↗
  • Dec 31, 25Giftamount n/aRainer M ErdtmannSee Remarks↗
  • Jan 31, 25Giftamount n/aRainer M ErdtmannSee Remarks↗
  • Jan 31, 25Giftamount n/aRainer M ErdtmannSee Remarks↗
  • Jan 31, 25Giftamount n/aRainer M ErdtmannSee Remarks↗
  • Jan 31, 25Giftamount n/aRainer M ErdtmannSee Remarks↗
  • Jan 31, 25Giftamount n/aRainer M ErdtmannSee Remarks↗
  • Jan 31, 25Giftamount n/aRainer M ErdtmannSee Remarks↗
  • Jan 28, 25Giftamount n/aRainer M ErdtmannSee Remarks↗
  • Nov 30, 24Compensation$3KFranco ValleChief Financial Officer↗
  • May 31, 24Compensation$3KJuan Pablo FriasChief Medical Officer↗
  • May 31, 24Compensation$17KFranco ValleChief Financial Officer↗
  • Dec 29, 23Giftamount n/aRainer M ErdtmannPresident and COO↗
  • Dec 29, 23Giftamount n/aRainer M ErdtmannPresident and COO↗
  • Dec 29, 23Giftamount n/aRainer M ErdtmannPresident and COO↗
  • Dec 29, 23Giftamount n/aRainer M ErdtmannPresident and COO↗
  • Dec 29, 23Giftamount n/aRainer M ErdtmannPresident and COO↗
  • Dec 29, 23Giftamount n/aRainer M ErdtmannPresident and COO↗
  • Dec 29, 23Giftamount n/aRainer M ErdtmannPresident and COO↗
  • Nov 30, 23Compensation$5KFranco ValleChief Financial Officer↗
  • May 31, 23Compensation$16KFranco ValleChief Financial Officer↗
  • Dec 28, 22Giftamount n/aRainer M ErdtmannPresident & COO↗

The full record holds 52 transactions and goes back to Apr 15, 21.

Its sector and its market

Biomea Fusion, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Biomea Fusion, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Biomea Fusion, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
273 documents on file, from Mar 12, 2021 to Oct 14, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Biomea Fusion, Inc. (BMEA): stock price history, insider trades and SEC filings — HornScout